Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2019-03-28 AGM Information
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Medinice S.A. na dzień 25 kwietnia 2019 r. (planowana zmiana Statutu Medinice S.A.) - Content (PL)
AGM Information Classification · 98% confidence The document text is an official announcement from the Management Board ('Zarząd') of Medinice S. A. regarding the convening of an Extraordinary General Meeting ('Nadzwyczajne Walne Zgromadzenie' or 'NWZ') scheduled for April 25, 2019. It details the agenda items, which include changing the Company's Statute and authorizing a capital increase. Crucially, the text states, 'W załączeniu pełna treść ogłoszenia (w tym projekty uchwał)...' (Attached is the full content of the announcement (including draft resolutions)...). This structure—a brief announcement about a meeting and its agenda, with the full details attached—strongly suggests this is a notice or proxy material related to a shareholder meeting, rather than the full minutes or voting results. Since the document announces the meeting and includes proxy voting instructions, it aligns best with materials sent to shareholders to solicit votes or provide information for a meeting. This points towards Proxy Solicitation & Information Statement (PSI) or potentially AGM Information (AGM-R) if it were the Annual General Meeting, but since it is an Extraordinary General Meeting (NWZ) and includes proxy instructions, PSI is the most precise fit among the options for pre-meeting materials. However, given the context of calling a general meeting, AGM-R (AGM Information) is often used broadly for general meeting notices, but PSI specifically covers proxy solicitation materials which are mentioned ('wzór formularza do wykonywania głosu na NWZ przez pełnomocnika'). Since the document is short and announces the meeting, it is a notice/solicitation material. PSI is the best fit for proxy/information statements related to meetings.
2019-03-28 Polish
Zawiadomienie_PS.pdf
Major Shareholding Notification Classification · 99% confidence The document is a formal notification in Polish ('Zawiadomienie') regarding a change in the percentage of voting rights held by a shareholder ('Akcjonariusz - Piotr Suwalski') in a public company (Medinice S.A.). It explicitly cites Article 69 of the Polish Public Offering Act concerning changes in total voting rights. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2019-03-27 Polish
Zawiadomienie o zmianie udziału w ogólnej liczbie głosów na Walnym Zgromadzeniu Akcjonariuszy Medinice S.A - Content (PL)
Major Shareholding Notification Classification · 95% confidence The document text is very short (260 characters) and announces a change in the number of votes held by a shareholder at the General Meeting (Walne Zgromadzenie). Specifically, it states that a shareholder's stake decreased due to the registration of new shares (serii E2). This directly relates to changes in significant share ownership thresholds or voting rights, which aligns best with the 'Major Shareholding Notification' (MRQ) category, as it details a change in the percentage of votes held by an entity. It is not a full report, an earnings release, or a director's dealing.
2019-03-27 Polish
Przeniesienie praw i obowiązków z umowy o dofinansowanie projektu grantowego pt. „Fundusz MediAlfa” - Content (PL)
Regulatory Filings Classification · 99% confidence The document text is very short (762 characters) and describes a significant corporate action: the transfer of rights and obligations related to a grant funding agreement ("Umowy przenoszącej prawa i obowiązki z umowy o dofinansowanie projektu grantowego") concerning a fund called "Fundusz MediAlfa" to a subsidiary. This action involves financing/investment activities (up to 25 million PLN investment in lifescience projects). This clearly falls under Capital/Financing Update (CAP) as it details a structural change enabling future financing/investment, rather than being a general regulatory announcement (RNS) or a specific M&A event (TAR). It is not an earnings release, dividend notice, or management change.
2019-03-22 Polish
Zawarcie umowy pośrednictwa sprzedaży produktów z Epmap-System GmbH& Co. KG - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement in Polish by Medinice S.A. (Emitent) regarding the signing of an agency agreement (Umowa pośrednictwa) with Epmap-System GmbH& Co. KG for exclusive sales intermediation in Poland. This describes a significant business transaction or partnership agreement. This type of event—a major contract signing that affects business operations and potentially future revenue—is typically classified as a significant corporate event announcement. It does not fit neatly into standard financial reports (10-K, IR, ER), management disclosures (MDA), or capital structure changes (CAP, SHA). Since it details a material agreement, it is best categorized as a general Regulatory Filing (RNS) as it is a mandatory disclosure of a significant event, or potentially a Legal/Transaction-related filing if a more specific category existed. Given the provided definitions, RNS serves as the most appropriate general regulatory disclosure category for material, non-standard announcements.
2019-03-05 Polish
Aktualizacja informacji na temat potencjalnej współpracy z Veritherme Medical B.V. - Content (PL)
M&A Activity Classification · 99% confidence The document text, written in Polish, discusses the termination of a Preliminary Memorandum of Understanding (MOU) with a Dutch company (Veritherme Medical B.V.) regarding potential recapitalization (dokapitalizowania) through new share issuance and the acquisition of technology rights. The key theme is the continuation of talks aimed at a future agreement involving capital structure changes and asset acquisition. Since the document is short (702 chars) and announces the status of negotiations related to financing/capital structure, it most closely aligns with 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it were a general update. Given the specific focus on 'dokapitalizowania' (recapitalization/financing), CAP is the most appropriate specific category, as it details an event related to fundraising/capital structure changes, even if the final agreement hasn't been reached yet.
2019-02-28 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.